Announced Tue, 26 May · 13:18 IST

Dear Sir, Submitting the Dislosure under Regulatiom 29(2) under SEBI (SAST) Regulation 2011. Sumitted by Vijaya Mani the Promoter and Director of the Company anaingt sell of her Equity ....

Promoter Stake Sell 1pctPromoter Below 50pctOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.2%1-day move
₹46.20
prior close
₹48.51
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+10.2+15.7+21.5+27.6+33.9+33.7+26.1+71.7+78.7
Up moveDown movePending
AI summary

Vijaya Mani, Promoter and Director of Colinz Laboratories Ltd, sold 3,78,000 equity shares in an off-market transaction on May 21, 2026. Before the sale, she held 12,48,500 shares representing 49.56% of the company's share capital. After the sale, her holding reduced to 8,70,500 shares representing 34.56%. The total share capital of the company remained unchanged at Rs. 2,51,91,000. The transaction was completed on May 23, 2026.

Likely market impact

This is a significant negative signal for shareholders as the promoter has reduced her stake by nearly 15 percentage points, crossing below the 50% threshold. This indicates reduced promoter commitment and may signal a lack of confidence in the company's prospects.